Featured Publications
Psychiatric and Substance Use Disorders and Related Service Use in the Diverse Black Sub-Populations in the United States
Jegede O, Na PJ, Rhee TG, Stefanovics EA, Rosenheck RA. Psychiatric and Substance Use Disorders and Related Service Use in the Diverse Black Sub-Populations in the United States. Journal Of Racial And Ethnic Health Disparities 2021, 9: 2237-2247. PMID: 34590245, DOI: 10.1007/s40615-021-01163-9.Peer-Reviewed Original ResearchMeSH KeywordsBlack or African AmericanBlack PeopleChildEmigrants and ImmigrantsHumansQuality of LifeSubstance-Related DisordersUnited StatesConceptsRelated service useSubstance use diagnosesSubstance use disordersService useUse diagnosesUse disordersRelated Conditions Wave IIILogistic regression analysisNational Epidemiologic SurveyDiverse black populationsAfrican AmericansMultinomial logistic regression analysisBlack/African AmericanBlack populationClinical characteristicsMethodsThe dataWave IIIEpidemiologic SurveyMeasures of qualityMental healthPhysical healthReference groupSubstance useGroup differencesBlack individualsRates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample
Jegede O, Rhee TG, Stefanovics EA, Zhou B, Rosenheck RA. Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample. Psychiatry Research 2022, 315: 114720. PMID: 35834863, DOI: 10.1016/j.psychres.2022.114720.Peer-Reviewed Original ResearchMeSH KeywordsAdultBehavior, AddictiveChildComorbidityDiagnosis, Dual (Psychiatry)HumansIll-Housed PersonsMental DisordersQuality of LifeSubstance-Related DisordersConceptsSubstance use disordersDual diagnosisPsychiatric disordersIndependent correlatesUse disordersDrug use diagnosesService use characteristicsPoor mental HRQOLRelated Conditions Wave IIINational Epidemiologic SurveyRepresentative US sampleMental HRQOLSUD diagnosisUse diagnosesTreatment needsEpidemiologic SurveyWave IIIAdult traumaMedical problemsSuicide attemptsDiagnosisDisordersAdultsFurther studiesSocial support
2024
What Would Equitable Harm Reduction Look Like?
Jegede O, Nunes J, Tumenta T, Black C, DeAquino J. What Would Equitable Harm Reduction Look Like? The AMA Journal Of Ethic 2024, 26: e572-579. PMID: 38958426, DOI: 10.1001/amajethics.2024.572.Peer-Reviewed Original ResearchMeSH KeywordsDrug UsersHarm ReductionHealth EquityHumansRacismSocial Determinants of HealthSocial JusticeSocial StigmaSubstance-Related DisordersConceptsDeterminants of health frameworkHarm reductionPerson-centered interventionsReduction programsPromote harm reductionHarm reduction strategiesHarm reduction programsHealth equityHealth frameworkEthnic inequalitiesSocial justiceDrug usePWUDOrganizational policiesMargin ExperimentReduction strategiesHarmCareStigmaProgramHealthRaciallyAntiracistInterventionJustice
2023
Monotonic Association of Increasing Past-Year Substance Use Disorder across a Four-Level Trauma Post-Traumatic Stress Disorder (PTSD) Hierarchy in a Nationwide Sample
Jegede O, Manhapra A, Zhou B, Rhee T, Rosenheck R. Monotonic Association of Increasing Past-Year Substance Use Disorder across a Four-Level Trauma Post-Traumatic Stress Disorder (PTSD) Hierarchy in a Nationwide Sample. Journal Of Dual Diagnosis 2023, 19: 231-239. PMID: 37796996, DOI: 10.1080/15504263.2023.2260339.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcohol-Related DisordersComorbidityHumansPrevalenceStress Disorders, Post-TraumaticSubstance-Related DisordersSurveys and QuestionnairesConceptsSubstance use disordersTrauma exposureCurrent PTSDUse disordersComparison of adultPast-year substance use disorderSUD prevalencePTSDRelated Conditions Wave IIINational Epidemiologic SurveyTrauma groupNationwide sampleDifferential effectsGreater likelihoodSUD diagnosisUnadjusted resultsClinical consequencesHierarchical groupsEpidemiologic SurveyWave IIIAdultsDisordersMonotonic associationPrior groupPrevalence
2021
Diagnostic remission of substance use disorders: Racial differences and correlates of remission in a nationally representative sample
Bommersbach TJ, Jegede O, Stefanovics EA, Rhee TG, Rosenheck RA. Diagnostic remission of substance use disorders: Racial differences and correlates of remission in a nationally representative sample. Journal Of Substance Use And Addiction Treatment 2021, 136: 108659. PMID: 34785084, DOI: 10.1016/j.jsat.2021.108659.Peer-Reviewed Original ResearchAdultAlcoholismAlcohol-Related DisordersEthnicityHispanic or LatinoHumansRace FactorsSubstance-Related DisordersUnited StatesTreatment of substance use disorders among black and white adults: rates, correlates, and racial discrimination
Bommersbach TJ, Jegede O, Na PJ, Stefanovics EA, Rhee TG, Rosenheck RA. Treatment of substance use disorders among black and white adults: rates, correlates, and racial discrimination. Journal Of Addictive Diseases 2021, 40: 345-356. PMID: 34747323, DOI: 10.1080/10550887.2021.1997038.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcohol-Related DisordersHumansRacial GroupsRacismSubstance-Related DisordersUnited StatesConceptsTreatment receiptPast-year SUDCriminal justice involvementSUD treatmentWhite individualsWhite adultsMultivariate analysisBlack individualsIndependent differentiating factorsSubstance use disorder treatmentUse disorder treatmentSubstance use disordersNational Epidemiologic SurveyRelated Conditions-IIILow social supportJustice involvementClinical correlatesRacial groupsPsychiatric disordersPsychiatric treatmentUse disordersEpidemiologic SurveyDisorder treatmentBivariate analysisSociodemographic disadvantage
2020
Perceived barriers to access care, anticipated discrimination and structural vulnerability among African Americans with substance use disorders
Jegede O, Muvvala S, Katehis E, Paul S, Soipe A, Jolayemi A. Perceived barriers to access care, anticipated discrimination and structural vulnerability among African Americans with substance use disorders. International Journal Of Social Psychiatry 2020, 67: 136-143. PMID: 32666877, DOI: 10.1177/0020764020934512.Peer-Reviewed Original ResearchMeSH KeywordsBlack or African AmericanHumansSocial StigmaSubstance-Related DisordersSurveys and QuestionnairesConceptsSubstance use disordersStigma subscalesUse disordersPsychiatric diagnosisAfrican AmericansAfrican American patientsTreatment-related stigmaAnticipated discriminationSubstance use servicesTotal mean scoreAmerican patientsTeaching hospitalCare EvaluationMental illnessHealth disparitiesHealth inequitiesMean scoreSignificant differencesDiagnosisAssessment toolCareDisordersStigmaSubscalesDiscrimination Survey
2019
Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection
Gayam V, Jegede O, Tiongson B, Mandal AK, Sidhu J, Garlapati P. Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection. Digestive Diseases 2019, 38: 232-239. PMID: 31494648, DOI: 10.1159/000502514.Peer-Reviewed Original ResearchConceptsHepatitis C virus infectionC virus infectionNon-psychiatric patientsPsychiatric patientsPsychiatric diagnosisAntiviral treatmentVirus infectionTreatment responsePsychiatric disordersComorbid hepatitis C virus (HCV) infectionDirect-acting antiviral treatmentRetrospective cohort observational studyComorbid substance use disorderNeuropsychiatric adverse effectsPrior treatment statusSustained virologic responseCohort observational studyPrimary psychiatric diagnosisComorbid substance abusePrimary care practicesSubstance use disordersHCV patientsVirologic responseHigh burdenObservational study